The Top 5
馃搱MarketsMonday, April 13, 2026

U.S. stocks slip as fragile Iran ceasefire fades and inflation concerns resurface

By Sam ReevesAI Politics Correspondent

The S&P 500 slid 0.11% to 6,816.89, and the Dow fell 0.56%, even as the Nasdaq edged up 0.35%. The gains from the week's fragile ceasefire appear to be unraveling amid fresh energy pressures.

Why it matters

Geopolitical tensions and rising energy costs threaten both near-term gains in your retirement portfolio and long-term inflation outlook.

The big picture

This sets the tone for investors at the start of earnings-heavy Wall Street week.

馃捇TechnologyFriday, June 5, 2026

Highly reviewed speaker can be hacked over the air to infect connected devices

By Alex RiveraAI Technology Reporter

A popular speaker model has been found to have vulnerabilities that allow it to be hacked remotely, potentially leading to the infection of connected devices.

Why it matters

This raises significant concerns about the security of smart home devices and the potential for widespread cyber attacks.

Details

The discovery highlights the risks associated with IoT devices, which can be exploited if not properly secured.

馃搱BusinessFriday, June 5, 2026

First Google, now Meta? Big Tech may increasingly sell stock to bankroll $820 billion AI boom.

By Pat MorganAI Business Reporter

Big Tech companies like Google and Meta are considering selling stock to fund the massive growth in AI, projected to be worth $820 billion.

Why it matters

This move could reshape the financial landscape of the tech industry and impact stock prices significantly.

Details

As AI continues to evolve, the need for substantial funding is driving these companies to explore unconventional financing methods.

馃敩ScienceFriday, June 5, 2026

AI-designed universal coronavirus vaccine passes first human trial

By Alex RiveraAI Technology Reporter

A new universal coronavirus vaccine, designed using artificial intelligence, has successfully completed its first human trial, showing promising results in safety and efficacy.

Why it matters

This development could revolutionize the approach to combating COVID-19 and future coronavirus outbreaks, potentially offering broader protection.

Details

The vaccine aims to provide a more comprehensive immune response compared to existing vaccines, which often target specific variants.

馃實WorldFriday, June 5, 2026

Putin says there is 'no point' meeting Zelensky over ending Ukraine war

By Sam ReevesAI Politics Correspondent

Russian President Vladimir Putin stated that there is no purpose in meeting Ukrainian President Volodymyr Zelensky to discuss the end of the ongoing conflict in Ukraine.

Why it matters

This statement underscores the ongoing tensions and lack of diplomatic progress in resolving the war in Ukraine.

Details

Putin's remarks come amid continued military actions and a stalemate in negotiations.

Sources

馃彞HealthFriday, June 5, 2026

AI-designed universal coronavirus vaccine passes first human trial

By Dr. WeiAI Science & Health Correspondent

A new universal coronavirus vaccine, designed using artificial intelligence, has successfully completed its first human trial, showing promising results.

Why it matters

This development could revolutionize the way we approach vaccinations for COVID-19 and other coronaviruses, potentially providing broader immunity.

Details

The vaccine aims to target multiple strains of the virus, which could lead to more effective and long-lasting protection.

Want more?

Get the brief delivered to your inbox 3x a week.

Subscribe Free